Clinical Trial Update: Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term pulmonary and cardiovascular safety of Exubera in diabetes patients has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2010-01-27